{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:30:40Z","timestamp":1787135440234,"version":"build-2736575974"},"reference-count":47,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Ambroxol is a high-potency inhibitor of voltage-gated sodium channels Nav1.7 and Nav1.8 responsible for nociceptive and neuropathic pain. This study investigated the analgesic property of ambroxol on corneal pain in rats as well as its toxicity on human corneal epithelial cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Inhibition of corneal sensation (CS) by ambroxol hydrochloride (AH) in Sprague\u2013Dawley rats was assessed by Cochet\u2013Bonnet esthesiometer. Rat corneal pain was induced by administering 5 M NaCl drops to the eyes, and eye wiping rates were recorded to reflect pain intensity. Subsequently, a rat neuropathic corneal pain (NCP) model was created by first removing the corneal epithelium and then provoking pain with 2 M NaCl. The analgesic property of 0.5% AH eye drop was assessed in rats by reductions in eye wiping rates. In cultured human corneal epithelial cells, the adverse effects of AH on cell migration and viability were studied by cell scratch and Cell Counting Kit-8 tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>It was noted that 0.5% AH could significantly inhibit CS, and 0.5% AH is efficacious in suppressing rat corneal pain as well as heightened nociceptor sensitivity from repetitive stimulation from irritants. At concentrations up to 30 \u03bcM, AH does not affect corneal epithelial cell migration, cell proliferation, and viability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Selective blockage of key nociceptors of the cornea by ambroxol is effective in suppressing corneal pain and heightened nociceptor excitability, leading to modulation of NCP. Sparing certain CS could translate into more protection to the ocular surface. No overt toxicity of ambroxol was seen in cultured human corneal epithelial cells in this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251391936","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:11:13Z","timestamp":1761585073000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ambroxol is Effective for Corneal Pain in Rats"],"prefix":"10.1177","volume":"42","author":[{"given":"Aoling","family":"Li","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene M.","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine, Rochester, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guigang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Arizona College of Medicine, Tucson, Arizona, USA."},{"name":"NeuVision Development LLC, Tucson, Arizona, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000154384.05614.8f"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-020-00263-9"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306280"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.03.015"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000389"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.051508.135531"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2015.1114853"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01429-2"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1744806919858801"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S207610"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.12.005"},{"issue":"7","key":"e_1_3_4_13_2","first-page":"143","article-title":"NaV1.7 inhibitors relieve ocular discomfort in a rat model of dry eye disease","volume":"61","author":"Delwig A","year":"2020","unstructured":"Delwig A, , Liu G, , Meng ID, et al. NaV1.7 inhibitors relieve ocular discomfort in a rat model of dry eye disease. Investigative Ophthalmology & Visual Science, 2020; 61(7):143.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.14.15"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002693"},{"issue":"4","key":"e_1_3_4_16_2","first-page":"646","article-title":"Results of some clinical-pharmacological studies on ambroxol (NA 872)","volume":"25","author":"Renovanz VK","year":"1975","unstructured":"Renovanz VK. Results of some clinical-pharmacological studies on ambroxol (NA 872). Arzneimittelforschung, 1975; 25(4):646\u2013652.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.8.1119"},{"issue":"12","key":"e_1_3_4_18_2","first-page":"557","article-title":"Antiinflammatory properties of ambroxol","volume":"13","author":"Beeh KM","year":"2008","unstructured":"Beeh KM, , Beier J, , Esperester A, et al. Antiinflammatory properties of ambroxol. Eur J Med Res, 2008; 13(12):557\u2013562.","journal-title":"Eur J Med Res"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(98)90506-6"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.10.058"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.3.433"},{"issue":"3","key":"e_1_3_4_22_2","first-page":"194","article-title":"Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept","volume":"52","author":"Schutz A","year":"2002","unstructured":"Schutz A, , Gund HJ, , Pschorn U, et al. Local anaesthetic properties of ambroxol hydrochloride lozenges in view of sore throat. Clinical proof of concept. Arzneimittelforschung, 2002; 52(3):194\u2013199.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13475"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-015-0060-y"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-05043-6"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2701004"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.02.016"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresprot.2005.10.003"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.30"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.1808"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181f7f363"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3182000af9"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225040-00002"},{"key":"e_1_3_4_34_2","article-title":"Topical NSAIDs: Best practices for safe use","author":"Burling-Phillips L","year":"2013","unstructured":"Burling-Phillips L. Topical NSAIDs: Best practices for safe use. EyeNet, 2013.","journal-title":"EyeNet"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.303"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00052.2017"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0468-18.2018"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-9-52"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.07.039"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001838"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13962"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040450"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.02.003"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071799"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-018-2579-4"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7941716"},{"issue":"1","key":"e_1_3_4_48_2","first-page":"511","article-title":"An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children","volume":"15","author":"Kantar A","year":"2020","unstructured":"Kantar A, , Klimek L, , Cazan D, et al. An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children. Multidiscip Respir Med, 2020; 15(1):511.","journal-title":"Multidiscip Respir Med"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251391936","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251391936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251391936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:15:05Z","timestamp":1787134505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251391936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.1177\/10807683251391936"],"URL":"https:\/\/doi.org\/10.1177\/10807683251391936","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}